147 related articles for article (PubMed ID: 31281016)
1. Structure-activity relationships study of neolamellarin A and its analogues as hypoxia inducible factor-1 (HIF-1) inhibitors.
Li G; Dong H; Ma Y; Shao K; Li Y; Wu X; Wang S; Shao Y; Zhao W
Bioorg Med Chem Lett; 2019 Aug; 29(16):2327-2331. PubMed ID: 31281016
[TBL] [Abstract][Full Text] [Related]
2. Molecular-targeted antitumor agents. 15. Neolamellarins from the marine sponge Dendrilla nigra inhibit hypoxia-inducible factor-1 activation and secreted vascular endothelial growth factor production in breast tumor cells.
Liu R; Liu Y; Zhou YD; Nagle DG
J Nat Prod; 2007 Nov; 70(11):1741-5. PubMed ID: 17958397
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and structure-activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF)-1 inhibitors.
Yasuda Y; Arakawa T; Nawata Y; Shimada S; Oishi S; Fujii N; Nishimura S; Hattori A; Kakeya H
Bioorg Med Chem; 2015 Apr; 23(8):1776-87. PubMed ID: 25773014
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of neolamellarin A, an inhibitor of hypoxia-inducible factor-1.
Arafeh KM; Ullah N
Nat Prod Commun; 2009 Jul; 4(7):925-6. PubMed ID: 19731594
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 3-(phenylethynyl)-1,1'-biphenyl-2-carboxylate derivatives as new HIF-1 inhibitors.
Wang S; Wang X; Shao Y; Shao K; Wang Y; Guo X; Dong H; Zhao W; Li Y; Li G
Bioorg Chem; 2021 Nov; 116():105298. PubMed ID: 34454298
[TBL] [Abstract][Full Text] [Related]
6. Protective Effects of Marine Alkaloid Neolamellarin A Derivatives against Glutamate Induced PC12 Cell Apoptosis.
Zhang K; Guan X; Zhang X; Liu L; Yin R; Jiang T
Mar Drugs; 2022 Apr; 20(4):. PubMed ID: 35447935
[TBL] [Abstract][Full Text] [Related]
7. Sodwanone and yardenone triterpenes from a South African species of the marine sponge Axinella inhibit hypoxia-inducible factor-1 (HIF-1) activation in both breast and prostate tumor cells.
Dai J; Fishback JA; Zhou YD; Nagle DG
J Nat Prod; 2006 Dec; 69(12):1715-20. PubMed ID: 17190448
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel antineoplastic agents inspired from marine bromopyrrole alkaloids.
Rane RA; Bangalore PK; Naphade SS; Patel HM; Palkar MB; Karpoormath R
Anticancer Agents Med Chem; 2015; 15(5):548-54. PubMed ID: 25495466
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway.
Shang FF; Wang JY; Xu Q; Deng H; Guo HY; Jin X; Li X; Shen QK; Quan ZS
Eur J Med Chem; 2021 Aug; 220():113474. PubMed ID: 33930802
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of neolamellarin a derivatives targeting heat shock protein 90.
Jiang L; Yin R; Wang X; Dai J; Li J; Jiang T; Yu R
Eur J Med Chem; 2017 Jul; 135():24-33. PubMed ID: 28426997
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and target identification of new hypoxia-inducible factor 1 (HIF-1) inhibitors containing 1-alkyl-1H-pyrazole-3-carboxamide moiety.
Sakai M; Takahashi N; Ikeda H; Furutani Y; Higuchi S; Suzuki T; Dohmae N; Kobayashi S; Harada H; Kojima S; Matsuura T; Hattori A; Kakeya H
Bioorg Med Chem; 2021 Sep; 46():116375. PubMed ID: 34492592
[TBL] [Abstract][Full Text] [Related]
12. Cardenolides from Calotropis gigantea as potent inhibitors of hypoxia-inducible factor-1 transcriptional activity.
Parhira S; Zhu GY; Chen M; Bai LP; Jiang ZH
J Ethnopharmacol; 2016 Dec; 194():930-936. PubMed ID: 27793783
[TBL] [Abstract][Full Text] [Related]
13. Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment.
Narise K; Okuda K; Enomoto Y; Hirayama T; Nagasawa H
Drug Des Devel Ther; 2014; 8():701-17. PubMed ID: 24944508
[TBL] [Abstract][Full Text] [Related]
14. Strongylophorines: natural product inhibitors of hypoxia-inducible factor-1 transcriptional pathway.
Mohammed KA; Jadulco RC; Bugni TS; Harper MK; Sturdy M; Ireland CM
J Med Chem; 2008 Mar; 51(5):1402-5. PubMed ID: 18278856
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Anticancer Activity of 3-(Substituted Aroyl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole Derivatives.
Zhan XP; Lan L; Wang S; Zhao K; Xin YX; Qi Q; Wang YL; Mao ZM
Chem Biodivers; 2017 Feb; 14(2):. PubMed ID: 27696660
[TBL] [Abstract][Full Text] [Related]
16. A-ring and E-ring modifications of the cytotoxic alkaloid Luotonin A: Synthesis, computational and biological studies.
Ibric A; Battisti V; Deckardt S; Haller AV; Lee C; Prötsch C; Langer T; Heffeter P; Schueffl HH; Marian B; Haider N
Bioorg Med Chem; 2020 May; 28(9):115443. PubMed ID: 32201190
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway.
Mooring SR; Jin H; Devi NS; Jabbar AA; Kaluz S; Liu Y; Van Meir EG; Wang B
J Med Chem; 2011 Dec; 54(24):8471-89. PubMed ID: 22032632
[TBL] [Abstract][Full Text] [Related]
18. Orobanone analogues from acid-promoted aromatization rearrangement of curcumol inhibit hypoxia-inducible factor-1 (HIF-1) in cell-based reporter assays.
Li YQ; Li GZ; Dong Y; Ma X; Dong HJ; Wu QQ; Zhao WJ
Bioorg Chem; 2019 Apr; 85():357-363. PubMed ID: 30658235
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives.
Shanab K; Schirmer E; Knafl H; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
Bioorg Med Chem Lett; 2010 Jul; 20(13):3950-2. PubMed ID: 20537894
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α inhibitors: synthesis and biological evaluation of novel moracin O and P analogues.
Xia Y; Jin Y; Kaur N; Choi Y; Lee K
Eur J Med Chem; 2011 Jun; 46(6):2386-96. PubMed ID: 21481991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
